Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Amortization - Intangibles (2016 - 2025)

Historic Amortization - Intangibles for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $2.6 million.

  • Angiodynamics' Amortization - Intangibles rose 165.38% to $2.6 million in Q4 2025 from the same period last year, while for Nov 2025 it was $10.5 million, marking a year-over-year decrease of 467.96%. This contributed to the annual value of $10.3 million for FY2025, which is 2092.27% down from last year.
  • Latest data reveals that Angiodynamics reported Amortization - Intangibles of $2.6 million as of Q4 2025, which was up 165.38% from $2.7 million recorded in Q3 2025.
  • Angiodynamics' 5-year Amortization - Intangibles high stood at $4.9 million for Q4 2021, and its period low was $2.5 million during Q2 2024.
  • For the 5-year period, Angiodynamics' Amortization - Intangibles averaged around $3.8 million, with its median value being $4.0 million (2021).
  • As far as peak fluctuations go, Angiodynamics' Amortization - Intangibles surged by 1395.35% in 2022, and later plummeted by 4209.09% in 2024.
  • Angiodynamics' Amortization - Intangibles (Quarter) stood at $4.9 million in 2021, then decreased by 1.88% to $4.8 million in 2022, then decreased by 25.12% to $3.6 million in 2023, then decreased by 27.78% to $2.6 million in 2024, then rose by 1.65% to $2.6 million in 2025.
  • Its last three reported values are $2.6 million in Q4 2025, $2.7 million for Q3 2025, and $2.6 million during Q2 2025.